Almdahl Sven M, Damstuen Jens, Eide Magne, Mølstad Per, Halvorsen Per, Veel Terje
Department of Cardiac Surgery, Feiring Heart Clinic, Feiring, Norway.
Interact Cardiovasc Thorac Surg. 2013 Feb;16(2):143-50. doi: 10.1093/icvts/ivs455. Epub 2012 Oct 31.
The anti-fibrillatory effect of potassium is well recognized from experimental models. There have, however, been very few clinical reports on the use of potassium to convert ventricular fibrillation (VF) after cardioplegic arrest.
In total, 8465 adult patients undergoing cardiac operations on cardiopulmonary bypass (CPB) and with cold antegrade crystalloid cardioplegic arrest were consecutively enrolled in a database. Patients with VF after removal of the aortic clamp were given 20 mmol potassium, and if needed an extra 10 mmol, in the perfusion line and the conversion rate was registered. Preoperative and intraoperative factors possibly related to the occurrence of post-ischaemic VF were assessed.
Of these, 1721 (20%) patients had VF and 1366 of these (79%) were successfully treated with potassium infusion. Only 355 (21%) patients (4% of all operations) had direct-current countershock. The need for pacing was lower in the treatment group compared with the non-treatment group (P <0.001). Multivariate analysis revealed as the main findings that age, gender, amount of cardioplegia related to body mass index (BMI), and blood transfusion during the time of CPB had a highly significant (P <0.001) impact on reducing the rate of post-arrest VF. Somewhat contrary to expectation, left ventricular hypertrophy (LVH) was not a significant factor (P = 0.32) for post-arrest VF. No conversion by potassium was significant for age (P <0.001), gender (P <0.001) and LVH (P <0.001), but not for blood transfusion during CPB (P = 0.38) and for the ratio of cardioplegia-BMI (P = 0.26).
The results from this register study demonstrate that potassium infusion is an effective and convenient first-hand measure to convert post declamping VF on CPB.
钾的抗纤颤作用在实验模型中已得到充分认识。然而,关于使用钾来转复心脏停搏后室颤(VF)的临床报告却非常少。
总共8465例接受体外循环(CPB)心脏手术且采用冷顺行晶体心脏停搏的成年患者连续纳入一个数据库。在移除主动脉夹后发生VF的患者在灌注管路中给予20 mmol钾,如有需要额外再给予10 mmol,并记录转复率。评估术前和术中可能与缺血后VF发生相关的因素。
其中,1721例(20%)患者发生VF,其中1366例(79%)通过输注钾成功治疗。只有355例(21%)患者(占所有手术的4%)接受了直流电除颤。治疗组的起搏需求低于未治疗组(P<0.001)。多因素分析显示,主要发现是年龄、性别、与体重指数(BMI)相关的心脏停搏量以及CPB期间的输血对降低停搏后VF发生率有高度显著(P<0.001)影响。与预期有些相反,左心室肥厚(LVH)不是停搏后VF的显著因素(P = 0.32)。钾转复对于年龄(P<0.001)、性别(P<0.001)和LVH(P<0.001)有显著意义,但对于CPB期间的输血(P = 0.38)和心脏停搏量与BMI的比值(P = 0.26)无显著意义。
这项登记研究的结果表明,输注钾是转复CPB后松开主动脉夹后VF的一种有效且便捷的首要措施。